Processing challenges with solid dosage formulations containing vitamin E TPGS

Pharmaceutical Development and Technology

Volumn 18, Issue 1, 2013, Pages 296-304

  Pandey, Preetanshu ^a   Sinko, Patrick D ^a   Bindra, Dilbir S ^a   Hamey, Rhye ^a   Gour, Shruti ^a   Vema Varapu, Chandra ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

Aeroperl 300; Colloidal silicon dioxide; Compaction; Dwell time; Vitamin E TPGS; Wet granulation

Indexed keywords

ALPHA TOCOPHEROL SUCCINATE; CROSCARMELLOSE SODIUM; HYDROXYPROPYLCELLULOSE; LACTOSE; MACROGOL; MAGNESIUM STEARATE; MICROCRYSTALLINE CELLULOSE; SILICON DIOXIDE;

ARTICLE; BATCH PROCESS; CHEMICAL MODIFICATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG DOSAGE FORM; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; ELASTICITY; FLUIDIZED BED; POROSITY; PRIORITY JOURNAL; SHEAR FLOW; SOLID; TABLET COMPRESSION; TABLET DISINTEGRATION; TABLET FRIABILITY; TABLET MANUFACTURE; TIME;

EID: 84870885071     PISSN: 10837450     EISSN: 10979867     Source Type: Journal    
DOI: 10.3109/10837450.2012.737807     Document Type: Article

References (17)

1. Jens-Uwe AHJ, Rainer HM. Nanocrystal technology, drug delivery and clinical applications. Int J Nanomedicine 2008;3:295-310.
2. Mohanachandran PS, Sindhumol PG, Kiran TS. Enhancement of solubility and dissolution rate: An overview. Pharmacie Globale (IJCP) 2010;4:1-10.
3. Hetal T, Bindesh P, Sneha T. A review on techniques for oral bioavailability of drugs. Int Pharm Sc Rev Res 2010;4:203-223.
4. Bajaj H, Bisht S, Yadav M, Singh V. Bioavailability enhancement: A review. Int J Pharma Bio Sc 2011;2:202-216.
5. Vemula VR, Lagishetty V, Lingala S. Solubility enhancement techniques. Int J Pharm Sc Review Res 2010;5:41-51.
6. Singh MC, Sayyad AB, Sawant SD. Review on various techniques of solubility enhancement of poorly soluble drugs with special emphasis on solid dispersion. J Pharm Res 2010;3: 2494-2501.
7. Sokol RJ, Johnson KE, Karrer FM, Narkewicz MR, Smith D, Kam I. Improvement of cyclosporin absorption in children after liver transplantation by means of water-Soluble vitamin E. Lancet 1991;338:212-214.
8. Dintaman JM, Silverman JA. Inhibition of P-glycoprotein by D-α-Tocopheryl polyethylene glycol 1000 succinate (TPGS). Pharm Res 1999;16:1550-1556. (Pubitemid 29510551)
9. Chang T, Benet LZ, Hebert MF. The effect of water-Soluble vitamin E on cyclosporine pharmacokinetics in healthy volunteers. Clin Pharmacol Ther 1996;59:297-303. (Pubitemid 26122201)
10. Wacher VJ, Wong S, Wong HT. Peppermint oil enhances cyclosporine oral bioavailability in rats: Comparison with D-α-ocopheryl poly(ethylene glycol 1000) succinate (TPGS) and ketoconazole. J Pharm Sci 2002;91:77-90. (Pubitemid 34074468)
11. Hong-Wei Wu S, Hopkins WK. Characteristics of D-α-Tocopheryl PEG 1000 succinate for applications as an absorption enhancer in drug delivery systems. Pharm Technol 1999:1-10.
12. Danjo K, Kamiya K, Otsuka A. Effect of temperature on the sticking of low-melting point materials. Chem Pharm Bull 1993;41:1423-1427. (Pubitemid 23285544)
13. Jin F, Tatavarti A. Tabletability assessment of conventional formulations containing Vitamin E tocopheryl polyethylene glycol succinate. Int J Pharm 2010;389:58-65.
14. Wu SH, Clipse NM, Yuan J. Application of vitamin E TPGS 1000 NF as a melt binder for making tablets. AAPS Pharm Sci 2003;5:AAPS Abstract 1053.
15. Yuan J, Clipse NM, Wu SH. Tablets comprising a poorly compressible active agent and tocopherol polyethyleneglycol succinate (TPGS). 2006. WO 2006/047067 A1.
16. Pandey P, Tao J, Chaudhury A, Ramachandran R, Gao GZ, Bindra DS. A combined experimental and modeling approach to study the effects of high-Shear wet granulation process parameters on granule characteristics. Pharm Dev Technol 2012, early online, doi:10.3109/10837450.2012.700933.
17. Wikberg M, Alderborn G. Compression characteristics of granulated materials IV. The effect of granule porosity on the fragmentation propensity and the compactability of some granulations. Int J Pharm 1991;69:239-253.